AbbVie (NYSE:ABBV) reported its Q4 earnings results on Wednesday, February 2, 2022 at 07:44 AM.
Here's what investors need to know about the announcement.
Also check this: NextEra Energy and 2 other stocks bought by insiders
Earnings
AbbVie beat estimated earnings by 0.91%, reporting an EPS of $3.31 versus an estimate of $3.28, which did not surprise analysts.
Revenue was up $1.03 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11, which was followed by a 4.56% increase in the share price the next day.
Here's a look at AbbVie's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 3.22 | 3.09 | 2.83 | 2.85 |
| EPS Actual | 3.33 | 3.11 | 2.95 | 2.92 |
| Revenue Estimate | 14.32B | 13.63B | 12.76B | 13.70B |
| Revenue Actual | 14.34B | 13.96B | 13.01B | 13.86B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
